The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis

  1. Christian S M Helker
  2. Annika Schuermann
  3. Cathrin Pollmann
  4. Serene C Chng
  5. Friedemann Kiefer
  6. Bruno Reversade
  7. Wiebke Herzog  Is a corresponding author
  1. University of Muenster, Germany
  2. Max Planck Institute for Molecular Biomedicine, Germany
  3. A*STAR, Singapore

Abstract

A key step in the de novo formation of the embryonic vasculature is the migration of endothelial precursors, the angioblasts, to the position of the future vessels. To form the first axial vessels, angioblasts migrate towards the midline and coalesce underneath the notochord. Vascular endothelial growth factor (Vegf) has been proposed to serve as a chemoattractant for the angioblasts and to regulate this medial migration. Here we challenge this model and instead demonstrate that angioblasts rely on their intrinsic expression of Apelin receptors (Aplr, APJ) for their migration to the midline. We further show that during this angioblast migration Apelin receptor signaling is mainly triggered by the recently discovered ligand Elabela (Ela). As neither of the ligands Ela or Apelin (Apln) nor their receptors have previously been implicated in regulating angioblast migration, we hereby provide a novel mechanism for regulating vasculogenesis, with direct relevance to physiological and pathological angiogenesis.

Article and author information

Author details

  1. Christian S M Helker

    n/a, University of Muenster, Muenster, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Annika Schuermann

    n/a, University of Muenster, Muenster, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Cathrin Pollmann

    n/a, Max Planck Institute for Molecular Biomedicine, Muenster, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Serene C Chng

    Institute of Medical Biology, Human Genetics and Embryology Laboratory, A*STAR, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  5. Friedemann Kiefer

    n/a, Max Planck Institute for Molecular Biomedicine, Muenster, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Bruno Reversade

    Institute of Medical Biology, Human Genetics and Embryology Laboratory, A*STAR, Sinagapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  7. Wiebke Herzog

    n/a, University of Muenster, Muenster, Germany
    For correspondence
    wiebke.herzog@mpi-muenster.mpg.de
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Tanya T Whitfield, University of Sheffield, United Kingdom

Ethics

Animal experimentation: All animal experiments were performed in strict accordance with the relevant laws and institutional guidelines the Max Planck Institute for Molecular Biomedicine, Muenster and the Institute of Medical Biology, Singapore. All protocols were approved by animal ethics committees of the state of North Rhine-Westfalia (Germany,# 39.32.7.1) and Singapore, respectively, and all efforts were made to minimize suffering.

Version history

  1. Received: January 27, 2015
  2. Accepted: May 22, 2015
  3. Accepted Manuscript published: May 27, 2015 (version 1)
  4. Version of Record published: June 16, 2015 (version 2)

Copyright

© 2015, Helker et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,979
    views
  • 790
    downloads
  • 89
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Christian S M Helker
  2. Annika Schuermann
  3. Cathrin Pollmann
  4. Serene C Chng
  5. Friedemann Kiefer
  6. Bruno Reversade
  7. Wiebke Herzog
(2015)
The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis
eLife 4:e06726.
https://doi.org/10.7554/eLife.06726

Share this article

https://doi.org/10.7554/eLife.06726

Further reading

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Nikola Sekulovski, Jenna C Wettstein ... Kenichiro Taniguchi
    Research Article

    Amniogenesis, a process critical for continuation of healthy pregnancy, is triggered in a collection of pluripotent epiblast cells as the human embryo implants. Previous studies have established that bone morphogenetic protein (BMP) signaling is a major driver of this lineage specifying process, but the downstream BMP-dependent transcriptional networks that lead to successful amniogenesis remain to be identified. This is, in part, due to the current lack of a robust and reproducible model system that enables mechanistic investigations exclusively into amniogenesis. Here, we developed an improved model of early amnion specification, using a human pluripotent stem cell-based platform in which the activation of BMP signaling is controlled and synchronous. Uniform amniogenesis is seen within 48 hr after BMP activation, and the resulting cells share transcriptomic characteristics with amnion cells of a gastrulating human embryo. Using detailed time-course transcriptomic analyses, we established a previously uncharacterized BMP-dependent amniotic transcriptional cascade, and identified markers that represent five distinct stages of amnion fate specification; the expression of selected markers was validated in early post-implantation macaque embryos. Moreover, a cohort of factors that could potentially control specific stages of amniogenesis was identified, including the transcription factor TFAP2A. Functionally, we determined that, once amniogenesis is triggered by the BMP pathway, TFAP2A controls the progression of amniogenesis. This work presents a temporally resolved transcriptomic resource for several previously uncharacterized amniogenesis states and demonstrates a critical intermediate role for TFAP2A during amnion fate specification.

    1. Developmental Biology
    2. Neuroscience
    Jingjing Liu, Yuedong Wang ... Yao Tian
    Research Article

    Axon projection is a spatial- and temporal-specific process in which the growth cone receives environmental signals guiding axons to their final destination. However, the mechanisms underlying changes in axonal projection direction without well-defined landmarks remain elusive. Here, we present evidence showcasing the dynamic nature of axonal projections in Drosophila’s small ventral lateral clock neurons (s-LNvs). Our findings reveal that these axons undergo an initial vertical projection in the early larval stage, followed by a subsequent transition to a horizontal projection in the early-to-mid third instar larvae. The vertical projection of s-LNv axons correlates with mushroom body calyx expansion, while the s-LNv-expressed Down syndrome cell adhesion molecule (Dscam1) interacts with Netrins to regulate the horizontal projection. During a specific temporal window, locally newborn dorsal clock neurons secrete Netrins, facilitating the transition of axonal projection direction in s-LNvs. Our study establishes a compelling in vivo model to probe the mechanisms of axonal projection direction switching in the absence of clear landmarks. These findings underscore the significance of dynamic local microenvironments in the complementary regulation of axonal projection direction transitions.